Trial Profile
Phase IIa standardized meal challenge study of insulin [BIOD-531] in patients with type 2 diabetes
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin glargine; Insulin lispro; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 17 Dec 2015 Status changed from recruiting to suspended, as per Biodel media release.
- 03 Nov 2015 Status changed from planning to recruiting.
- 14 Oct 2015 New trial record